Argentine Registry of Crohn's Disease and Ulcerative Colitis
Recruiting · NCT07155148 · Observational (researchers observe without assigning treatment) · Lead sponsor: Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
View the official record on ClinicalTrials.gov →Interventions studied
observational study
What this trial is about
RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Group (GADECCU). The registry will include outcomes of routine clinical practice of patients with IBD including the pediatric and adult population.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic, laboratory, and histopathological aspects, as well as small bowel imaging studies
Exclusion criteria
- Suspected IBD diagnosis without confirmation
- IBD patients with incomplete information about therapy and follow-up
Where it is running
2 locations listed.
- Hospital Privado Universitario de Cordoba - Córdoba, Córdoba Province, Argentina
- Hospital Privado Universitario de Cordoba - Córdoba, Córdoba Province, Argentina